Skip to content

Posts by David M. Langenau, PhD


Dr. David Langenau received his BS and MS from the University of Notre Dame and his PhD in Biology and Biomedical Sciences from Harvard Medical School in 2004. He next completed his fellowship training at Children’s Hospital Boston in 2008. Along with Dr. A. Thomas Look, he is credited with developing the first transgenic zebrafish model of cancer. In his own group, he has made seminal discoveries underlying the pathogenesis of pediatric acute lymphoblastic leukemia and rhabdomyosarcoma.

Mass General Cancer Center

An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.